,i  #aafth ,,congress  #b;d ,session    
,h4 ,r4 #fbad  ,,in ,,the ,,house ,,of  
,,representatives  ,march #ab1 #bjbj,mr4
 ,kind 7for himself1 ,mrs4 ,trahan1 and 
,ms4 ,barragn7 introduced the following 
bill2 which was referred to the         
,committee on ,ways and ,means1 and in  
addition to the ,committee on ,energy   
and ,commerce1 for a period to be       
subsequently determined by the ,speaker1
 in each case for consideration of such 
provisions as fall within the           
jurisdiction of the committee concerned 
,a ,,bill  ,to amend title ,,xviii of   
the ,social ,security ,act to provide   
for coverage of testing for ,,covid-#ai 
at no cost sharing under the ,medicare  
,advantage program4  #a4 ,coverage of   
testing for ,,covid-#ai at no cost      
sharing under the ,medicare ,advantage  
program  7a7 ,in general ,section       
#aheb7;a77#a77;,b7 of the ,social       
,security ,act 7#db ,u4,s4,c4           
#aciew-#bb7;a77#a77;,b77 is amended--   
7#a7 in clause 7iv7-- 7,a7 by           

redesignating subclause 7,,iv7 as       
subclause 7,,vi72 and  7,b7 by inserting
 after subclause 7,,iii7 the following  
new subclauses3  7,,iv7 ,in vitro       
diagnostic products 7as defined in      
section #hji4c7;a7 of title #ba1 ,code  
of ,federal ,regulations7 administered  
during any portion of the emergency     
period defined in paragraph 7#a77;,b7 of
 section #aace7;g7 beginning on or after
 the date of the enactment of clause    
7vi7 for the detection of               
,,sars-,co,v-#b or the diagnosis of the 
virus that causes ,,covid-#ai that are  
approved1 cleared1 or authorized under  
section #eaj7k71 #eac1 #eae or #efd of  
the ,federal ,food1 ,drug1 and ,cosmetic
 ,act1 and the administration of such in
 vitro diagnostic products4  7,v7       
,specified ,,covid-#ai testing-related  
services 7as described in section       
#ahcc7;cc77#a77 for which payment would 
be payable under a specified outpatient 
payment provision described in section  
#ahcc7;cc77#b74  2  7#b7 in clause 7v71 

by inserting 1 other than subclauses    
7,,iv7 and 7,v7 of such clause1 after   
clause 7iv72 and  7#c7 by adding at the 
end the following new clause3  7vi7     
,prohibition of application of certain  
requirements for ,,covid-#ai testing ,in
 the case of a product or service       
described in subclause 7,,iv7 or 7,v71  
respectively1 of clause 7iv7 that is    
administered or furnished during any    
portion of the emergency period         
described in such subclause beginning on
 or after the date of the enactment of  
this clause1 an ,,ma plan may not impose
 any prior authorization or other       
utilization management requirements with
 respect to the coverage of such a      
product or service under such plan4  4  
7b7 ,implementation ,the ,secretary of  
,health and ,human ,services may        
implement the amendments made by this   
section by program instruction or       
otherwise4